Corcept Therapeutics Incorporated
IT ˙ BIT ˙ US2183521028
62,12 € ↑0,86 (1,40%)
2026-06-03
DEL PRIS
SecurityIT:1CORT / Corcept Therapeutics Incorporated
InstitutionCaption Management, LLC
Latest Disclosed Ownership260,000 shares
Latest Disclosed Value $ 10,480,600
Caption Management, LLC ownership in 1CORT / Corcept Therapeutics Incorporated

On May 15, 2026 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 260,000 shares of Corcept Therapeutics Incorporated (IT:1CORT) valued at $8,798,400 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of Corcept Therapeutics Incorporated. The current value of the position is $16,151,200 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (1CORT) in the form of stock options. The firm currently holds call options representing 162,000 of underlying shares valued at $6,530,220 USD and put options representing 993,100 of underlying shares valued at $40,031,861 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1CORT / Corcept Therapeutics Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 260,000 260,000 10,481 0.0612
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -34,000 -100.00 0 -100.00
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 34,000 34,000 2,826 0.0220
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -27,000 -100.00 0 -100.00
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 27,000 27,000 680 0.0103
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -22,800 -100.00 0 -100.00
2022-02-11 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 22,800 22,800 451 0.0051
2021-08-16 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -4,000 -100.00 0 -100.00
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 4,000 4,000 95 0.0020
2020-08-14 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -20,000 -100.00 0 -100.00
2020-05-15 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 20,000 -3,900 -16.32 237 -17.71 0.0134
2020-02-13 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 23,900 23,900 288 0.0097
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -40,000 -100.00 0 -100.00
2019-08-13 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 40,000 33,100 479.71 446 450.62 0.0225
2019-05-14 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 6,900 6,900 81 0.0045
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM Call 162,000 -50.83 6,530 -43.05 n/a n/a n/a
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM Call 329,500 734.18 11,467 249.36 n/a n/a n/a
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM Call 39,500 -51.65 3,283 -45.26 n/a n/a n/a
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM Call 81,700 -23.36 5,997 -50.75 n/a n/a n/a
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS COM Call 106,600 30.80 12,176 196.52 n/a n/a n/a
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM Call 81,500 16.43 4,107 26.77 n/a n/a n/a
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM Call 70,000 -20.09 3,240 13.81 n/a n/a n/a
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM Call 87,600 484.00 2,846 654.91 n/a n/a n/a
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM Call 15,000 0.00 378 -22.59 n/a n/a n/a
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS COM Call 15,000 -50.00 487 -40.39 n/a n/a n/a
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM Call 30,000 817 n/a n/a n/a
2022-08-15 2022-06-30 13F CORCEPT THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM Call 70,000 100.00 1,577 127.56 n/a n/a n/a
2022-02-11 2021-12-31 13F CORCEPT THERAPEUTICS COM Call 35,000 693 n/a n/a n/a
2021-08-16 2021-06-30 13F CORCEPT THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS COM Call 65,000 1,547 n/a n/a n/a
2021-02-16 2020-12-31 13F CORCEPT THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F CORCEPT THERAPEUTICS COM Call 25,000 -28.57 435 -26.27 n/a n/a n/a
2020-08-14 2020-06-30 13F CORCEPT THERAPEUTICS COM Call 35,000 -33.33 590 -5.60 n/a n/a n/a
2020-05-15 2020-03-31 13F CORCEPT THERAPEUTICS COM Call 52,500 -21.05 625 -22.36 n/a n/a n/a
2020-02-13 2019-12-31 13F CORCEPT THERAPEUTICS COM Call 66,500 805 n/a n/a n/a
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-13 2019-06-30 13F CORCEPT THERAPEUTICS COM Call 40,000 100.00 446 89.79 n/a n/a n/a
2019-05-14 2019-03-31 13F CORCEPT THERAPEUTICS COM Call 20,000 235 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM Put 993,100 -11.29 40,032 2.75 n/a n/a n/a
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM Put 1,119,500 38,959 n/a n/a n/a
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM Put 100,000 -83.69 7,340 -89.52 n/a n/a n/a
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS COM Put 613,300 484.10 70,051 1,224.22 n/a n/a n/a
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM Put 105,000 16.67 5,291 27.01 n/a n/a n/a
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM Put 90,000 350.00 4,165 541.76 n/a n/a n/a
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM Put 20,000 -68.99 650 -60.04 n/a n/a n/a
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM Put 64,500 330.00 1,625 233.47 n/a n/a n/a
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS COM Put 15,000 -50.00 487 -40.39 n/a n/a n/a
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM Put 30,000 817 n/a n/a n/a
2022-08-15 2022-06-30 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM Put 70,000 100.00 1,577 127.56 n/a n/a n/a
2022-02-11 2021-12-31 13F CORCEPT THERAPEUTICS COM Put 35,000 693 n/a n/a n/a
2021-08-16 2021-06-30 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS COM Put 65,000 1,547 n/a n/a n/a
2020-11-16 2020-09-30 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F CORCEPT THERAPEUTICS COM Put 35,000 -33.33 590 -5.60 n/a n/a n/a
2020-05-15 2020-03-31 13F CORCEPT THERAPEUTICS COM Put 52,500 -21.05 625 -22.36 n/a n/a n/a
2020-02-13 2019-12-31 13F CORCEPT THERAPEUTICS COM Put 66,500 805 n/a n/a n/a
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-13 2019-06-30 13F CORCEPT THERAPEUTICS COM Put 40,000 100.00 446 89.79 n/a n/a n/a
2019-05-14 2019-03-31 13F CORCEPT THERAPEUTICS COM Put 20,000 235 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.